Important note

This AI stock analysis for GE HealthCare is not up to date. Creating and accessing our AI stock Analysis (powered by our data and Chat GPT) is only available for our premium users. Sign up to get access today!

GE HealthCare - AI Stock Analysis

Analysis generated March 14, 2025

GE HealthCare is a global medical technology and digital solutions innovator, dedicated to providing integrated diagnosis and support services to healthcare institutions. With a history of reliable service and innovation, GE HealthCare is a trusted partner for hospitals, clinics, and research institutions alike. The company's broad portfolio includes imaging, ultrasound, patient care solutions, and various services that enhance the delivery of diagnostic and therapeutic services to patients worldwide.

Fundamental Analysis

GE HealthCare's revenue for the last quarter was $4.86 billion, reflecting a modest increase of 0.50% compared to the previous quarter and an increase of 0.85% compared to the same quarter last year. This incremental growth serves as a positive indicator for investors, suggesting stable revenue streams and potential for future scalability.

Net income for the last quarter was $470 million, marking a significant increase of 9.81% compared to the previous quarter and an impressive 25.33% YOY growth. This indicates strong profitability and efficient operational management. A net income rise at such a rate showcases the company's ability to convert revenue into profit effectively.

The EBITDA for the last quarter was $753 million, with a 9.29% increase from the previous quarter and a 6.66% YOY growth. Consistent EBITDA growth signifies robust operating performance, essential for sustaining long-term growth and maintaining a healthy balance sheet.

The current P/E ratio stands at 19.31, an indicator of market sentiment and valuation. This figure is within a normal range, neither too high nor too low, reflecting investor confidence and balanced market expectations.

Technical Analysis

GE HealthCare's current stock price is $81.90, which is an 11.18% decrease compared to a month ago. Over the past year, the stock has dropped by 8.27%, hinting at potential long-term concerns among investors. The overall trend appears bearish, which could be worrisome for short-term investors.

The SMA10 is currently at 84.80, slightly down from the previous SMA10 of 85.04, suggesting a downward price trend. The Relative Strength Index (RSI) is at 60.2, indicating a neutral condition. While not overbought or oversold, this neutral RSI underscores the ambiguity among traders about the stock's near-term direction.

Alternative Data Analysis

In terms of job postings and employee sentiment, GE HealthCare currently has 1,468 open positions, a 53% increase in the last couple of months. This substantial rise suggests the company is in expansion mode, which can be seen as a healthy sign indicating future growth prospects. However, the business outlook among employees remains neutral, neither too optimistic nor pessimistic.

Regarding customer acquisition, the company has seen an estimated 1.7 million visitors to their webpage, up by 7% recently. This bullish trend could signify an increase in potential customers, further boosting future revenue streams. Additionally, on the customer engagement front, GE HealthCare has 65,000 Instagram followers, a 3% increase, indicating rising interest. However, Twitter followers remain consistent at 110,000, with no recent growth, suggesting a mixed outcome in social media engagement.

AltIndex’s AI score for GE HealthCare is 66, which provides a buy signal. This score predicts the stock price by integrating fundamental, technical, and alternative data, giving a comprehensive perspective that favors a positive investment outlook.

Conclusion and Recommendation

Based on the comprehensive analysis of fundamental, technical, and alternative data, GE HealthCare poses an interesting investment opportunity. The fundamental indicators such as steady revenue growth, substantial net income improvement, and a balanced P/E ratio, underline the company's strong financial health. However, the bearish trend in stock price and neutral RSI suggests caution in the short term.

The mixed signals from alternative data, such as robust job postings and increased webpage visitors countered by stagnant social media growth, also provide a balanced view. Despite these concerns, AltIndex's AI score of 66 leans towards a buy signal, indicating potential upside.

Therefore, the recommendation is to cautiously consider GE HealthCare as a viable addition to a diversified investment portfolio, particularly for those with a longer-term investment horizon.

Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.